Denmark's Chr Hansen is considering breaking up into two separate
entities, one focused on food and pharmaceutical ingredients and
the other a pharmaceutical pure-play making allergy vaccines and
asthma treatments, activities...
The ingredients division of Danish company Chr Hansen pulled in a
DKK 369 million (€49m) profit for the fiscal year on sales of DKK
3.4 billion (€460m), a slight dip on the previous year on rising